FBS Global (FBGL) restores Nasdaq minimum bid price compliance after deficiency
Rhea-AI Filing Summary
FBS Global Limited reports that it has regained compliance with Nasdaq’s minimum bid price requirement. Nasdaq confirmed that from February 12, 2026 through February 26, 2026, the Company’s ordinary shares closed at $1.00 per share or higher for 10 consecutive business days.
This closes a deficiency matter that began when the shares traded below $1.00 for 30 consecutive business days, triggering notices and a 180-day extension to cure the issue until May 11, 2026. Nasdaq has now confirmed compliance with Listing Rule 5550(a)(2), and the listing issue is considered resolved.
Positive
- Nasdaq compliance restored: The company’s ordinary shares closed at $1.00 or above for 10 consecutive business days through February 26, 2026, leading Nasdaq to confirm compliance with Listing Rule 5550(a)(2) and close the prior minimum bid price deficiency matter.
Negative
- None.
Insights
Regaining Nasdaq bid-price compliance removes a key listing risk.
FBS Global Limited confirms its ordinary shares traded at $1.00 or more for 10 straight business days from February 12–26, 2026. This satisfies Nasdaq Listing Rule 5550(a)(2), reversing the earlier deficiency tied to sub-$1.00 prices.
Previously, the company had received a deficiency notice and an additional 180-day compliance period running to May 11, 2026. With Nasdaq now stating the matter is closed, the immediate risk of a bid-price-related delisting is removed, though future compliance will still depend on maintaining qualifying share prices.